Clinical Trials

Clinical trials help researchers develop new and better treatments. The information they provide is the only way for medical breakthroughs to reach the public. Imaging plays a crucial role in these trials by providing detailed, non-invasive insights into how treatments affect the body. See below for ongoing Clinical trials by faculty members of the Yale Biomedical Imaging Institute.

Clinical Trials

BreastA Phase 1/2, Open-label, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ETX-636, a Pan-mutant-selective PI3Kα Inhibitor, as Monotherapy and in Combination With Other Anticancer Therapies in Participants With Advanced Solid Tumors
BreastA Phase 1b/2, Open-Label, Multicohort Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Point of Care Lung Ultrasound Examination in Patients with Shortness of Breath
Not accepting volunteers
A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)
BreastShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients With Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy With HER2 Blockade